Friday, June 19, 2015

New EUR 6 million EU Horizon 2020 research project launched using stem cell therapy to treat diabetic kidney disease (via CORDIS)

A new EUR 6 million research project (NEPHSTROM) has been funded by the European Union Horizon 2020 programme to evaluate the clinical safety and efficacy of a next-generation cell therapy discovered by Galway-based Orbsen Therapeutics, to combat diabetic kidney disease.

from EUROPA - Syndicated Research News Feed http://ift.tt/1GVt2Ho
via IFTTT

No comments:

Post a Comment